Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

PRODUCT NAME

VALSPARCOATES MODIFIED EPOXY SIZE

NFPA

PRODUCT USE

Exterior size coating for metal packaging. Application is by roller coater; either sheet
fed or coil fed. Coating is baked / cured in a ventilated conveyor oven. The use of a
quantity of material in an unventilated or confined space may result in increased exposure
and an irritating atmosphere developing.Before starting consider control of exposure by
mechanical ventilation.

SYNONYMS

"metal packaging exterior size coating"

Section 2 - HAZARDS IDENTIFICATION

CANADIAN WHMIS SYMBOLS

EMERGENCY OVERVIEW

RISK

May cause SENSITIZATION by skin contact.
HARMFUL - May cause lung damage if swallowed.
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.
Flammable.
Vapors may cause dizziness or suffocation.
Toxic to aquatic organisms, may cause long- term adverse effects in the aquatic
environment.

POTENTIAL HEALTH EFFECTS

ACUTE HEALTH EFFECTS

SWALLOWED

  Accidental ingestion of the material may be harmful; animal experiments indicate that ingestion of less than 150 gram may be fatal or may produce serious damage to the health of the individual.  Not a likely route of entry into the body in commercial or industrial environments. The liquid may produce considerable gastrointestinal discomfort and be harmful or toxic if swallowed. Ingestion may cause nausea, pain and vomiting. Vomit entering the lungs by aspiration can cause inflammation of the lungs, which can lead to death.  

EYE

  This material can cause eye irritation and damage in some persons.  The material may produce severe irritation to the eye causing pronounced inflammation. Repeated or prolonged exposure to irritants may produce conjunctivitis.  

SKIN

  Skin contact with the material may be harmful; systemic effects may resultfollowing absorption.  This material can cause inflammation of the skin oncontact in some persons.  Toxic effects may result from skin absorption.  Exposure limits with "skin" notation indicate that vapor and liquid may be absorbed through intact skin. Absorption by skin may readily exceed vapor inhalation exposure. Symptoms for skin absorption are the same as for inhalation. Contact with eyes and mucous membranes may also contribute to overall exposure and may also invalidate the exposure standard.  Bare unprotected skin should not be exposed to this material.  The material may accentuate any pre-existing skin condition.  The material may cause skin irritation after prolonged or repeated exposure and may produce on contact skin redness, swelling, the production of vesicles, scaling and thickening of the skin.  

INHALED

  If inhaled, this material can irritate the throat andlungs of some persons.  Inhalation hazard is increased at higher temperatures.  Acute effects from inhalation of high concentrations of gas / vapor are pulmonary irritation, including coughing, with nausea; central nervous system depression - characterized by headache and dizziness, increased reaction time, fatigue and loss of co-  ordination.  If exposure to highly concentrated solvent atmosphere is prolonged this may lead to narcosis, unconsciousness, even coma and possible death.  

CHRONIC HEALTH EFFECTS

  Skin contact with the material is more likely to cause a sensitization reaction in some persons compared to the general population.  

  Principal routes of exposure are usually by inhalation of vapor and skin contact / absorption of the material.  Chronic solvent inhalation exposures may result in nervous system impairment and liver and blood changes. [PATTYS].  Prolonged or continuous skin contact with the liquid may cause defatting with drying, cracking, irritation and dermatitis following.  As with any chemical product, contact with unprotected bare skin; inhalation of vapor, mist or dust in work place atmosphere; or ingestion in any form, should be avoided by observing good occupational work practice.  One ingredient of the product has caused skin sensitization reactions, shown as localized reddening and hives, or may produce respiratory sensitization characterized by asthma-  like symptoms and runny nose.